Sponsor
Farmak JSC
Vul. Kyrylivska 63, 04080
About the sponsor
Farmak JSC’s clinical research activity is centered on bioequivalence evaluation for oral fixed-dose combination products, with a focus on comparing a company-developed medicine against an established reference treatment in healthy subjects.
- Cardiovascular medicines
- Angiotensin receptor-neprilysin inhibition
- Fixed-dose combination therapy
The sponsor’s current research interest lies in the therapeutic area of heart failure treatment support through development of comparable medicines containing sacubitril and valsartan.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.